Federal award
ROCHE DIAGNOSTICS CORPORATION
W81K0023P0198
Contract
Obligated and Ceiling
- Obligated (net)
- $1,001,716.64
- Ceiling (potential value, not spending)
- $3,524,806.52
- Current value
- $1,001,716.64
- Gross positive obligations
- $1,682,059.96
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ROCHE HOLDING AG · WJHDT127L353
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0023P0198
- Award type code
- B
- Actions
- 6 · Aug 22, 2023 to Apr 4, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 4, 2025 | FY2025 | P00005 | C | −$280,343.32 | — |
| Dec 20, 2024 | FY2025 | P00004 | C | $841,029.96 | — |
| Jul 11, 2024 | FY2024 | P00003 | C | −$400,000.00 | — |
| May 23, 2024 | FY2024 | P00002 | G | $0.00 | — |
| Nov 17, 2023 | FY2024 | P00001 | C | $841,030.00 | — |
| Aug 22, 2023 | FY2023 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.